Oxford Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134K | Buy |
54,801
+42,492
| +345% | +$104K | 0.05% | 438 |
|
|
2025
Q1 | $82.1K | Buy |
+12,309
| New | +$82.1K | 0.04% | 420 |
|
|
2018
Q3 | – | Sell |
-17,303
| Closed | -$334K | – | 1885 |
|
|
2018
Q2 | $334K | Sell |
17,303
-29,078
| -63% | -$561K | 0.01% | 1465 |
|
|
2018
Q1 | $870K | Buy |
+46,381
| New | +$870K | 0.02% | 997 |
|
|
2017
Q1 | – | Sell |
-25,298
| Closed | -$617K | – | 1461 |
|
|
2016
Q4 | $617K | Buy |
+25,298
| New | +$617K | 0.02% | 555 |
|
|
2016
Q3 | – | Sell |
-3,975
| Closed | -$118K | – | 840 |
|
|
2016
Q2 | $118K | Buy |
+3,975
| New | +$118K | ﹤0.01% | 727 |
|
|
2016
Q1 | – | Sell |
-2,519
| Closed | -$115K | – | 880 |
|
|
2015
Q4 | $115K | Buy |
+2,519
| New | +$115K | ﹤0.01% | 830 |
|